This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Mood Disorder
+3

A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression

Sponsored by University of California, Davis

About this trial

Last updated 7 years ago

Study ID

200715749

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 65 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 15 years ago

What is this trial about?

This is a pilot project to study if repetitive Transcranial Magnetic Stimulation (rTMS) will benefit patients with bipolar depression safely. Based on published studies, this study hypothesizes that rTMS on the left dorsal prefrontal lobe will improve symptoms in some patients who have failed at least two medications.

What are the participation requirements?

Yes

Inclusion Criteria

- bipolar I or II patients, currently in a depression episode

- Patient must have failed at least 2 medication

- Score of 21-item Hamilton Rating Scale for Depression (HAM-D)

No

Exclusion Criteria

- Rapid cycling bipolar or mixed episode of mood disorder by definition of current DSM criteria

- Substantial risk of suicide during the screening period that requires inpatient care

- Presence of psychosis

- Dual diagnosis of other primary, currently clinically significant severe mental disorders

- History of other significant neurological diseases, such as seizure disorder, stroke, brain tumors, abnormalities in the blood vessels in brain, dementia, Parkinson's disease, Huntington's chorea or multiple sclerosis

- History of any medical event that may increase the risk of having seizure, such as head trauma with unconsciousness for more than 5 minutes or a family history of seizure

- Significant medical complications that may deteriorate during the trial or have increased likelihood of danger consequences

- Patients who are pregnant or intend to become pregnant during the study period

- Any metallic prosthesis in head, neck or upper body (including cardiac pace maker) that cannot be safely removed during treatment

- Current Vagus Nerve Stimulation (VNS) treatment or Electroconvulsive Therapy (ECT) treatment, or with history of failed ECT treatment

- Patient's Motor Threshold for TMS cannot be detected

- Significant side effects which are intolerable during the screening or any later stage of the trial

- Started psychotherapy within the previous 8 weeks or foreseeable psychotherapy will be started or changed in 6 weeks

Locations

Location

Status